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Childhood bacterial meningitis (BM) is a devastating disease 
that affects children worldwide. The incidence, death rate, and 
complications are, however, higher in developing countries. 
Many aspects of the disease, such as outcome prediction, still 
remain unclear. Any means to predict the outcome would be 
helpful for clinicians, particularly in resource-poor settings.
Auditory brain stem responses (ABRs) reflect the neural 
activity along the auditory pathway in the brain stem. Auditory 
brain stem responses can be used to (1) indirectly evaluate 
hearing (especially in small children) and (2) evaluate the 
intactness of the brain stem in patients with, eg, tumors, trauma, 
or infections involving the brain stem.
Auditory brain stem response recordings often show altera-
tions in conditions that affect brain stem structures, such as 
acoustic neuroma or other tumors, central pontine myelinoly-
sis, and multiple sclerosis. However, neuroradiological imaging 
has widely replaced ABRs in otoneurological diagnostics. 
Auditory brain stem response monitoring is, nonetheless, still 
useful in posterior fossa surgery and can help distinguish drug-
induced coma from true central nervous system (CNS) dam-
age.1 In comatose patients, ABRs can serve to assess the 
prognosis,2 although the cause of coma affects the prognostic 
value of ABR.1 In adults, the prognostic value is more notable 
in head trauma than in brain anoxia. In head trauma, normal 
ABRs have positive predictive values of 90% for awakening 
and 75% to 80% for good outcome, whereas major alterations 
(distortion or disappearance of peaks II-V) are associated with 
death or vegetative state.3 In anoxic coma, normal ABRs have 
no prognostic value, whereas abnormal ABRs (loss of brain 
stem components III-V), although rarely seen, are associated 
with ominous prognosis.3
In hypoxic-ischemic encephalopathy, severely abnormal 
ABRs (distorted or abolished) in newborns older than 35 weeks’ 
gestational age predict ominous outcome2–4 and in older 
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ABSTRACT
OBjeCTiVe: To assess the role of single and repeated auditory brain stem response (ABR) in predicting mortality and severe neurological 
injury among children having bacterial meningitis (BM) in Luanda, Angola.
MeThOdS: The morphology of ABR traces of 221 children (aged 2 months to 12 years) from admission day was analyzed and compared 
with age-matched normative data. Absence and delay of traces were compared with mortality and mortality or severe neurological injury in 
subgroup analyses. Outcome was also evaluated with repeated ABR of 166 children based on presence or absence of responses at 80 dB 
nHL (normal hearing level) stimulation level.
ReSuLTS: Individually, the absence of typical ABR waveform did not signify poor outcome. At the group level, latencies and interpeak laten-
cies (IPLs) were significantly prolonged among patients with BM in comparison with controls, and the prolongation correlated with higher 
mortality or severe neurological sequelae.
COnCLuSiOnS: We confirmed the effect of BM on neural conduction time in auditory pathway. However, ABR in similar settings seems not 
useful for individual prognostication, although at the group level, delayed latencies, IPLs, or both associated with poorer outcome.
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children can provide predictive value of survival versus death.5 
In posttraumatic coma, ABRs together with somatosensory 
evoked potentials can also indicate prognostic value, with 
absent evoked potentials predicting death.6 Studies of children 
with coma due to different causes found that patients with 
ABR abnormalities had a greater probability of dying than 
patients with a normal ABR.7,8
Alterations in ABR patterns have also been described in 
CNS infections.9–12 In a study of 50 children diagnosed with 
BM, overall abnormalities were detected in 64% of patients, 
including prolonged peak latencies and interpeak latencies 
(IPLs), unilateral, and bilateral absent responses.9 Studies 
including 24 to 50 children with tuberculous meningitis also 
reported lengthening of latencies and IPLs, absence of waves, 
and reduction in I/V ratio.13–15
As the mortality and neurological injuries remain high for 
BM, and the disease might affect the brain stem structures 
via several mechanisms, we aimed to evaluate the role of 
ABRs in predicting the outcome after BM in a post hoc 
analysis of a large prospective pediatric cohort in Luanda, 
Angola. More specifically, we hypothesized that (1) missing 
or delayed ABRs would signify unfavorable outcome and 
that (2) BM affects the conduction properties of the brain 
stem structures.
Methods
Our study forms a part of a large (N = 723) randomized treat-
ment trial on childhood BM (ISRCTN62824827) aiming to 
improve treatment outcome with a slow initial β-lactam infu-
sion and paracetamol in children 2 months to 13 years in the 
Hospital Pediátrico David Bernardino, Luanda, Angola, 
between 2005 and 2008 (described in detail in the original 
publication).16 The ethics committee of the local hospital 
approved the study including the ABR protocol. Trained phy-
sicians explained the study to the child’s parent or guardian, 
who provided written consent prior to enrollment. In case of 
illiteracy, the consent was signed with a fingerprint.
Bacterial meningitis was diagnosed with a positive culture 
or polymerase chain reaction from cerebrospinal fluid (CSF) or 
with BM-compatible symptoms and signs and either a positive 
blood culture or at least 2 of the following: high CSF leukocyte 
concentration (>100 × 106/L, predominantly polymorphs), pos-
itive for Gram staining, positive for latex agglutination test, or 
serum C-reactive protein concentration higher than 
381 nmol/L (40 mg/L). All patients received cefotaxime treat-
ment, an antimicrobial not classified as ototoxic.
A total of 357 ABR traces recorded on admission day (within 
24 hours) were available. After excluding patients with abnormal 
or unknown ear status on pneumatic otoscopy (T.P.), we included 
Figure 1. Flow of patients diagnosed with bacterial meningitis included in the study.
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ABR traces from 221 children (age range: 2 months to 12 years) 
and 166 corresponding follow-up traces after 7 days (±1 day). 
Figure 1 presents the flow of patients included in the study.
ABR protocol and characterization
Before initiating the trial, study nurses received detailed train-
ing to perform 1-channel ABR recording. An ENT specialist 
(A.P.) programmed the appliance settings and protocol for the 
ABR procedure. Study doctor (T.P.) performed pneumatic 
otoscopy and the study nurses recorded the ABR responses 
with MADSEN Octavus BERA (Otometrics, Taastrup, 
Denmark) at predetermined time points.
The recording was performed bedside in natural sleep or in 
a comfortable position, with child usually held on his or her 
parent’s lap. The electrodes were positioned on the mastoids 
and the high forehead for 1-channel ABR recording. The audi-
tory stimuli (a broadband click) with rarefaction polarity were 
delivered using headphones to both ears separately with inten-
sities of 80, 60, and 40 dB nHL (normal hearing level) at a rate 
of 20 Hz, whereas the contralateral side received masking with 
20-dB lower stimuli. In total, 2000 sweeps were averaged. The 
potential differences between the ipsilateral mastoid and the 
vertex electrode (Cz) were recorded, whereas the mastoid elec-
trode at the nonstimulated ear served as a neutral electrode. 
Analysis window was of 10.5 ms. A band-pass filter of 300 to 
1000 Hz was used for analysis. The project manager (T.P.) 
monitored the measuring procedures throughout the study.
The authors of the study (A.S. and M.K.), both trained for 
ABR evaluation, evaluated the responses by visual analysis. The 
study authors were blinded to the outcome of each patient. An 
expert audiologist (A.A.A.) was consulted if necessary. In 
Figure 2, one normal ABR trace is shown as an example.
We measured the peak latencies of waves I, III, and V when 
they were identifiable from the traces to 80-dB nHL clicks and 
calculated the IPLs I to III, III to V, and I to V in those 114 
subjects in whom all the 3 responses were identifiable. The 
better ear was chosen for analysis with asymmetrical cases. If 
no V wave was noted from either side, the recording was con-
sidered bilaterally absent.
The ABR latency and IPL parameters were compared with 
age-matched control values obtained from 101 children (63 
men and 38 women; age range from 1 month to 13 years), out-
patients, or their siblings of the same hospital. The upper limit 
of normal was defined as mean +2 SD of control. Table 1 pre-
sents the characteristics of the control population. Table 2 
shows the normative values for age groups derived from control 
children.
We compared the characterized ABR type (bilateral absent 
or delay of latency parameters) with (1) fatal outcome alone 
and (2) death combined with severe neurological sequelae in all 
patients and separately in those with altered level of conscious-
ness (Glasgow Coma Scale [GCS] < 15) and coma (GCS < 7) 
and also for infants (<1 year) and children ≥1 year of age.
Auditory brain stem responses were dichotomized as fol-
lows. If ABRs were bilaterally or unilaterally present, they were 
considered as present. If the responses were absent from both 
sides, the ABRs were considered as absent. Paired traces were 
available from 166 children. These children were divided into 4 
groups based on the repeated ABR recordings. In group 1, the 
responses were absent in both recordings, and in group 2, they 
shifted from present to absent. In group 3, the responses were 
present in both recordings, and in group 4, the initially absent 
traces turned present in the control recording.
For group comparisons of latencies and IPLs between 
patients and controls, the subjects were divided into 2 age 
groups, less than and more than 24 months, as after 24 months 
the latencies do not shorten markedly.17
Statistical analyses
Dichotomous categorical variables were compared using χ2 test 
and continuous variables using nonparametric Mann-Whitney 
U test, as the data did not follow normal distribution. P < .05 
Figure 2. Auditory brain stem response recorded from a child having bacterial meningitis on admission day to hospital. The trace is recorded from left 
side with 80-dB nHL stimulation level.
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was considered statistically significant. A logistic regression 
model was used to examine the predictive value of repeated 
ABR.
Results
The children were overall very ill and often came to hospital 
after several days of illness with altered level of consciousness. 
Of the 221 patients (age range: 2 months to 12 years) included 
in the study, 22 were diagnosed with severe neurological 
sequelae determined as blindness, quadriplegia, severe psy-
chomotor retardation, or hydrocephalus at discharge. Of 
patients, 42 died before and 13 patients after the follow-up 
recording on the seventh day of hospitalization. Mortality 
rate was lower in infants (<1 year of age, 19%) than in older 
children (≥1 year of age, 28%). Figure 3 presents different 
types of ABR traces from the study.
In the successfully recorded 221 patients, the absence 
(N = 107, 48%) of typical ABR waveform (ie, absent ABR, 
Figure 3C) on the admission day did not signify fatal outcome 
(80% survived the follow-up period) or poor outcome combin-
ing death and severe neurological sequelae. In the subgroup 
analyses including only children with altered consciousness or 
coma, there was a correlation neither between absent ABR and 
death nor between absent ABR and death or severe neurologi-
cal sequelae. In the age-specific analyses, performed separately 
for age groups <1 year and ≥1 year of age, absent ABR did not 
indicate a statistical relationship with mortality or mortality 
combined with severe neurological injury at hospital (Table 3).
We further examined a possible association between abnor-
mal ABR latency parameters and poor outcome in those chil-
dren with ABRs present. Delayed latencies of waves III or V or 
IPLs correlated with a higher rate of mortality or severe neuro-
logical sequelae (P = .024). The same was true in the subgroup 
analysis, which included only patients with altered level of con-
sciousness (P = .043). However, in the age group analyses, the 
correlation was significant only in children ≥1 year of age 
(P = .008). Table 4 presents the characteristics and outcome of 
patients with abnormal latency and IPL parameters.
We then evaluated the value of repeating the ABR assess-
ment for outcome prediction. Table 5 presents the results of the 
paired ABR recordings in the 4 groups. Initially absent ABR 
remained absent in 63 children and appeared present in 16 chil-
dren. Of these children, 5 (8%) and 0 (0%) died, respectively. Of 
the initially present ABRs, 11 shifted to absent in the control 
measurement; 3 (27%) of these patients died. Of the 76 patients 
whose responses remained present, only 5 (7%) died. In logistic 
regression analyses, belonging to a certain group did not associ-
ate with death or severe neurological sequelae significantly.
We also performed group-level comparisons of the latency 
parameters between the patients with BM and the controls as 
Table 1. Characteristics of control population from Luanda.
MEdIAN, N IQR, %  
Control patients, all 101 100  
 Age, mo 47 62  
 Male sex 63 62  
 ABR RESPONSE NO ABR RESPONSE
 MEdIAN, N IQR, % MEdIAN, N IQR, %
All 65 64 36 36
 Age, mo 47 62.5 40.5 63.5
 Male sex 39 60 24 67
Reason for visiting hospital
 General pediatrics, control/consultation 19 30 11 31
 Surgical, control/consultation 40 63 24 67
 Accompanying family member 4 6 1 3
diagnosed with acute infection 28 44 9 25
 Respiratory infection 25 40 8 22
 Gastroenteritis 2 3 0 0
 Other 1 2 1 3
Excluded, otorrhea 1 2 0 0
Abbreviations: ABR, auditory brain stem response; IQR, interquartile range.
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well as between survived and deceased patients with BM. Table 
6 shows the age group–specific ABR characteristics in the 114 
patients with BM (with all responses present) compared with 
the control population (n = 64). There was a significant differ-
ence between the BM children and the control population in 
the latency of wave V (P = .001) and IPLs of III to V (P = .005) 
and I to V (P = .003) in infants and small children <24 months 
and in children older than 24 months in waves I (P = .041), III 
(P = .003), and V (P = .001) and IPLs of I to III (P = .04) and I 
to V (P = .019). In patients, these latencies were delayed. No 
significant difference was detected between survived and 
deceased patients.
Discussion
We studied the prognostic value of ABRs in childhood BM in 
a developing country setting. Despite the relatively large sam-
ple size, our findings contradict our first hypothesis that absent 
ABRs at hospitalization would show prognostic value in these 
very ill children under these circumstances. However, in the 
patients in whom the responses were successfully recorded, the 
Table 2. Age-related ABR latency and IPL values calculated from 64 control children.
AGE GROUP LATENCy/IPL MEAN Sd +2 Sd UPPER LIMIT
≤6 mo
N = 7 I 1.66 0.30 2.25
III 4.26 0.35 4.96
V 6.13 0.56 7.25
I-III 2.61 0.29 3.19
III-V 1.86 0.34 2.54
I-V 4.47 0.57 5.61
7–12 mo
N = 8 I 2.01 0.26 2.52
III 4.28 0.32 4.93
V 6.05 0.32 6.69
I–III 2.27 0.22 2.72
III–V 1.78 0.07 1.91
I–V 4.05 0.21 4.46
13–24 mo
N = 13 I 1.71 0.20 2.12
III 4.10 0.37 4.85
V 5.73 0.36 6.46
I–III 2.39 0.34 3.08
III–V 1.63 0.33 2.28
I–V 4.02 0.33 4.68
>24 mo
N = 39 I 1.68 0.33 2.34
III 3.81 0.32 4.44
V 5.55 0.44 6.43
I–III 2.13 0.38 2.88
III–V 1.74 0.24 2.23
I–V 3.87 0.41 4.69
Abbreviations: ABR, auditory brain stem response; IPL, interpeak latency.
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Figure 3. Auditory brain stem responses (ABRs) recorded from 3 children having bacterial meningitis with normal pneumatic otoscopy on admission day 
to hospital. (A) ABR with normal latencies and interpeak latencies (IPLs), elevated hearing threshold. (B) delayed latency of wave V and IPLs of I to V and 
III to V, right ear, obtained from a 48-month-old child who died. (C) Bilateral absent response.












 NO. (%) NO. (%)
Bilateral absent response
 All 107 23 (43) 84 (50) NS 35 (46) 72 (50) NS
 <GCS 68 22 (46) 46 (50) NS 33 (49) 35 (49) NS
delayed latency of waves III, V, or IPL
 All 33 12 (40) 21 (26) NS 17 (43) 16 (22) .024
 <GCS 23 10 (40) 13 (28) NS 15 (44) 8 (22) .043
 <1 y 17 3 (60) 14 (38) NS 6 (50) 11 (37) NS
 ≥1 y 16 9 (36) 7 (16) NS (.051) 11 (39) 5 (12) .008
Abbreviations: ABR, auditory brain stem response; GCS, Glasgow Coma Scale; IPL, interpeak latency; NS, nonsignificant.
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mortality rate combined with severe neurological sequelae was 
significantly higher with delayed response in all patients and in 
children ≥1 year of age, and the mortality rate alone was higher 
in children ≥1 year of age.
With repeated ABR measurements, the percentage of fatal 
outcome for those whose ABR remained or turned absent 
(11%, N = 8/74) was higher than for those whose ABR per-
sisted or turned present (5%, N = 5/92). However, this was not 
Table 5. Repeated auditory brain stem response traces recorded on days 0 and 7, divided into 4 groups.
GROUP 1 2 3 4 ALL









N = 63 (38) N = 11 (7) N = 76 (46) N = 16 (10) N = 166 (100)
death at discharge 5 (8) 3 (27)b 5 (7) 0 (0) 13 (8)
Severe neurological 
sequelae at discharge
8 (13) 1 (9) 9 (12) 2 (13) 20 (12)
Any neurological sequelae 
at discharge
35 (56) 7(64) 31 (41) 11 (69) 84 (51)
Profound hearing loss at 
control (0-3 mo)
0 (0) 1 (9) 3 (4) 1 (6) 5 (3)
aObtainable (present) recording from at least one side or unobtainable (absent) bilateral recording at 80 dB nHL stimuli.
bIn addition, 3 deaths after discharge.
Table 6. ABR latencies and IPLs from patients and controls with normal ear status on pneumatic otoscopy.
PATIENTS CONTROLS P VALUE
All N = 114 N = 64  
Age <24 mo N = 61 N = 25  
 Mean/median (Sd/IQR)  
 Median age 7 (8) 11(11.5) NS
 I latency 1.85 (0.26) 1.78 (0.29) NS
 III latency 4.34 (0.45) 4.20 (0.36) NS
 V latency 6.30 (0.44) 5.93 (0.46) .001
 IPL I–III 2.48 (0.37) 2.43 (0.33) NS
 IPL III–V 1.93 (0.30) 1.80 (0.20) .005
 IPL I–V 4.45 (0.40) 4.15 (0.43) .003
Age ≥24 mo N = 53 N = 39  
 Mean/median (Sd/IQR)  
 Median age 54 (43.5) 71 (49) NS
 I latency 1.80 (0.29) 1.66 (0.22) .041
 III latency 4.05 (0.40) 3.80 (0.32) .003
 V latency 5.83 (0.51) 5.55 (0.44) .001
 IPL I–III 2.30 (0.34) 2.12 (0.38) .04
 IPL III–V 1.78 (0.27) 1.75 (0.24) NS
 IPL I–V 3.97 (0.44) 3.81 (0.42) .019
Abbreviations: ABR, auditory brain stem response; IPL, interpeak latency; IQR, interquartile range; NS, nonsignificant.
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statistically significant. Furthermore, our findings suggest 
that meningitis affects the conduction time of neural impulses 
in the auditory pathway in the brain stem, prolonging the 
ABR latencies.
Although studies of coma with traumatic origin and stroke 
showed prognostic value of progressive ABR degradation in 
adults in bedside recordings,18 we failed to find similar results 
in our patients with childhood BM in a developing country 
setting. The few studies of meningitis, but of different causes, 
have ended up with the same result. In Japanese encephalitis, 
ABR abnormalities correlated with brain stem lesions on 
computed tomographic and magnetic resonance imaging 
scans, but not with severity of coma or outcome.12 As in corti-
cal evoked responses from primary somatosensory and audi-
tory cortex in comatose patients,19 the cause of altered level of 
consciousness seems to play a major role when the prognostic 
value of ABR is studied.
As in this study of BM, more subtle ABR pattern changes 
at the group level, especially the lengthening of absolute and 
IPLs, have been previously reported in meningitis of varying 
causes, such as tuberculous13,14 and mixed cause.13,14
Our study has some limitations. First of all, hearing loss is a 
well-known sequelae of childhood BM, which causes elevation 
in the ABR thresholds or deafness unilaterally or bilaterally. 
Hearing loss fluctuation is known to occur in the course of the 
disease20,21 and was also observed in the original cohort.22 This 
might explain some of the variance and lability in our ABR 
results. Processes causing conductive hearing loss may also pro-
long the absolute ABR latencies. The IPLs, however, are not 
markedly affected by the conductive or sensorineural dysfunc-
tions in the outer or inner ear level. In addition, in our study 
design, the repeated measurement was set for quite late, whereas 
the occurrence of death usually happened early after the hospi-
talization. Accordingly, in our setting, we could only measure 
the late in-hospital mortality of the disease.
Medication may also affect the ABR tracings. Even though 
the ABR is thought to be affected minimally by sedatives or 
anesthetics, other medications may have an effect on the inner 
ear. In our study, we did not use ototoxic antibiotics. However, 
some of the patients did use antibiotics prior to hospitalization 
that we were not able to control. Finally, 31% of our patients 
had positive malaria smear and most of them were given qui-
nine. Although quinine is thought to raise the hearing thresh-
old only to a lesser degree and after the loading dose, its role 
particularly in the first ABR testing remains unclear.
Finally, the ABR was not performed in quiet laboratory set-
tings, nor could we control the examination room temperature, 
availability of electricity, or interference in the hospital, which 
sometimes complicated performing the ABR testing. Thus, 
ABR was not tested with all children initially or at the preset 
control time.
The missing brain stem–evoked responses (waves III and 
V) could be validated if the wave I was present in ABR, thus 
confirming the activation of the auditory system. However, the 
signal-to-noise ratio of the recordings did not permit this anal-
ysis, meaning that the absent ABRs may possibly be a result of 
inadequate stimulation or recording. This may explain the lack 
of prognostic value of the missing ABR at hospitalization. 
However, to partly overcome this obstacle in a developing 
country setting, we analyzed the follow-up recordings to obtain 
validation from repeated recording. We are aware that our 
results do not apply to ABR recordings performed in a neuro-
physiology laboratory. However, because our aim was to test 
the prognostic value of ABRs particularly in a developing 
country setting, we believe our data demonstrate that in such 
settings absent ABRs at hospitalization are unable to provide 
prognostic information in patients with BM.
Conclusions
To the best of our knowledge, this is the largest study assessing 
the role of ABR in prognosis of childhood BM in a developing 
country setting. At the group level, we observed that childhood 
BM affects the neural conduction time in the auditory neural 
pathway in brain stem. However, at the individual level, we 
found no clear benefit from a single ABR recording in predict-
ing the outcome. In other words, even absent ABRs in similar 
settings cannot be taken as an indication for poor outcome. 
However, delayed latencies of waves III or V or IPLs correlated 
with a higher rate of mortality or severe neurological sequelae. 
The role of delayed latency and IPL parameters in individual 
prognostication deserves further confirmation.
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